Sign inJoin waitlistJoin the waitlist

Albert Park

Chief of Pediatric Oto · Univ of Utah Sch of Med

Credentials: · · · ·

History

Pediatric Oto Division · Univ of Utah Sch of Med
Present
Univ of Utah Sch of Med
Present
Huntsman Cancer Institute & Hospital
Present

Orthopaedic Trauma
2001–2002
The Hospital for Sick Children
2000–2001
Otolaryngology – Head and Neck Surgery
Loyola University Medical Center
1995–2000
General Surgery
Loyola University Medical Center
1990–1995
Washington University School of Medicine
1986–1990
Swarthmore College
1982–1986

Research

Mitigation of tracheobronchomalacia with 3D-printed personalized medical devices in pediatric patients
Science Translational Medicine · 2015 · 285 citations
Cost-effectiveness of Universal and Targeted Newborn Screening for Congenital Cytomegalovirus Infection
JAMA Pediatrics · 2016 · 150 citations
Outcomes From a Hearing-Targeted Cytomegalovirus Screening Program
PEDIATRICS · 2017 · Last of 5 authors · 100 citations

HM
Harlan Muntz
17 papers
Christopher Nielson
11 papers · 5 as a resident
Marshall Smith
11 papers
Johannes Grimmer
9 papers
SM
Stephanie McVicar
8 papers
AH
Anna Holley
7 papers · 7 as a resident
Jeremy Meier
7 papers · 4 as a fellow
Mark Schleiss
7 papers
AH
Andrew Hotaling
6 papers
MD
Melanie Duval
6 papers
TH
Travis Haller
5 papers · 5 as a resident
Emily Huang
4 papers · 1 as a resident

Grants

Cochlear Resident Tissue Macrophages in Normal Cochlear Development and the Response to CMV Infection
National Institute on Deafness and Other Communication Disorders · R01
PI · $1.9M · Utah State Higher Education System--University of Utah
2024–2029
A Randomized Trial to Determine the Role of Valganciclovir for Asymptomatic Cytomegalovirus Infected Hearing Impaired Infants
National Institute on Deafness and Other Communication Disorders · U01
Contact PI · $2.6M · Utah State Higher Education System--University of Utah
2017–2022

Clinical trials

Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants
Principal investigator · Terminated · Phase 2
Albert Park
2018–2022